[Analysis of predictive factors of mortality in dilated cardiomyopathy. A cooperative study by the Cardiomyopathy Working Group]. 1990

M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
Service de cardiologie, hôpital Pitié-Salpêtrière, Paris.

An analysis of factors predictive of mortality was undertaken in a group of 201 patients with dilated cardiomyopathy (163 men, 38 women; average age 46 +/- 11 years) using a multivariate analysis (Cox's model) of 51 clinical electrocardiographic, echocardiographic and haemodynamic parameters. The average follow-up period was 57.1 +/- 29.9 months. Fifty-six patients died and the probability of 5-year survival was 77 +/- 3 per cent. The best predictive factor of survival was determined by the combination of the following parameters: presenting symptom: pulmonary oedema, peripheral oedema, syncope; duration of symptoms before inclusion into the study; left ventricular end diastolic volume; left ventricular end diastolic dimension; systolic pulmonary artery pressure. A quantitative score "S" was calculated which enabled identification of 3 subgroups: A (S less than 4.5); B (4.5 less than S less than 6); C (S greater than 6). The probability of 5-year survival was 90 +/- 5 per cent in Group A, 84 +/- 4 per cent in Group B and 53 +/- 7 per cent in Group C. CONCLUSIONS global survival was relatively long in this patient population with dilated cardiomyopathy at different stages of evolution; the combination of factors related to clinical severity, left ventricular dilatation, systolic pulmonary artery pressure and duration of symptoms allows identification of a subgroup of patients with a poor prognosis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D002423 Cause of Death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint. Causes of Death,Death Cause,Death Causes
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D004562 Electrocardiography Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY. 12-Lead ECG,12-Lead EKG,12-Lead Electrocardiography,Cardiography,ECG,EKG,Electrocardiogram,Electrocardiograph,12 Lead ECG,12 Lead EKG,12 Lead Electrocardiography,12-Lead ECGs,12-Lead EKGs,12-Lead Electrocardiographies,Cardiographies,ECG, 12-Lead,EKG, 12-Lead,Electrocardiograms,Electrocardiographies, 12-Lead,Electrocardiographs,Electrocardiography, 12-Lead
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
December 1994, British heart journal,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
November 1992, Zhonghua nei ke za zhi,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
June 1996, Journal of cardiac failure,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
January 2019, The Turkish journal of pediatrics,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
March 1998, International journal of cardiology,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
July 1984, The American journal of cardiology,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
August 1994, Journal of the National Medical Association,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
December 2023, ESC heart failure,
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
December 1993, Lancet (London, England),
M Komajda, and J P Jais, and B Goldfarb, and J B Bouhour, and Y Juillières, and J Lanfranchi, and P Peycelon, and P Geslin, and D Carrie, and Y Grosgogeat
January 1989, Annales de medecine interne,
Copied contents to your clipboard!